Patents

City of Hope is pleased to offer licensing opportunities for the patented or patent-pending scientific developments and discoveries. City of Hope is prepared to make appropriate supporting documentation available to parties who express an interest in the commercialization or further development of these technologies. To receive additional information on commercial licensing opportunities please contact Dr. George Megaw, at 626-301-8841.

Diamond, D.J. and York, J. Immuno-reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,074,645, June 13, 2000

Diamond, D. J. and York, J. Immuno-reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,156,317, December 5, 2000

Diamond, D.J. Immuno-Reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,251,399, June 26, 2001

Diamond, D.J. Immunoreactive peptide CTL epitopes of cytomegalovirus pp150. Patent # 6,544,521, April 8, 2003

Diamond, D.J. Immuno-Reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,562,345, May 13, 2003

Diamond, D.J. CTL Epitope Analogs. Patent # 6,632,435. October 14, 2003

Diamond, D.J. Immuno-Reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,726,910, April 27, 2004

Diamond, D.J. HCMV-reactive T cells and uses thereof. Patent # 6,727,093, April 27, 2004

Diamond, D.J. Diagnostic Reagents for Human Cytomegalovirus and Methods of use. Patent # 6,733,973, May 11, 2004

Diamond, D.J. Immuno-Reactive Peptide CTL Epitopes of Human Cytomegalovirus. Patent # 6,843,992, January 18, 2005

Diamond, D.J. CTL Epitope Analogs. Patent # 6,951,651, October 4, 2005.

Diamond, D.J. Diagnostic reagents for human cytomegalovirus and methods of use. Patent # 7,160,685, January 9, 2007.

Diamond, D.J. and Wang, Z. Human cytomegalovirus antigens expressed in MVA and methods of use. Patent # 7,163,685, January 16, 2007.

Ellenhorn, J. and Diamond, D.J. Modified vaccinia Ankara expressing p53 in cancer immunotherapy. Patent # 7,256,137, August 14, 2007.